Novartis AG
OTC:NVSEF

Watchlist Manager
Novartis AG Logo
Novartis AG
OTC:NVSEF
Watchlist
Price: 137.655 USD -0.5% Market Closed
Market Cap: 283B USD

Wall Street
Price Targets

NVSEF Price Targets Summary
Novartis AG

Wall Street analysts forecast NVSEF stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVSEF is 131.511 USD with a low forecast of 106.131 USD and a high forecast of 158.981 USD.

Lowest
Price Target
106.131 USD
23% Downside
Average
Price Target
131.511 USD
4% Downside
Highest
Price Target
158.981 USD
15% Upside
Novartis AG Competitors:
Price Targets
LAURUSLABS
Laurus Labs Ltd
17% Downside
COLL
Collegium Pharmaceutical Inc
5% Upside
4507
Shionogi & Co Ltd
7% Downside
600521
Zhejiang Huahai Pharmaceutical Co Ltd
21% Upside
ELAN
Elanco Animal Health Inc
7% Upside

Revenue
Forecast

Revenue Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 4 years is 5%.

-1%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 4 years is 12%.

3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-24%
Average Miss

Net Income
Forecast

Net Income Estimate
Novartis AG

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 4 years is 16%.

2%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVSEF's stock price target?
Price Target
131.511 USD

According to Wall Street analysts, the average 1-year price target for NVSEF is 131.511 USD with a low forecast of 106.131 USD and a high forecast of 158.981 USD.

What is Novartis AG's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Novartis AG's revenue is -1%. The projected CAGR for the next 4 years is 5%.

What is Novartis AG's Operating Income forecast?
Projected CAGR
12%

For the last 13 years the compound annual growth rate for Novartis AG's operating income is 3%. The projected CAGR for the next 4 years is 12%.

What is Novartis AG's Net Income forecast?
Projected CAGR
16%

For the last 13 years the compound annual growth rate for Novartis AG's net income is 2%. The projected CAGR for the next 4 years is 16%.

Back to Top